The NA audit for biopharma: Key issues & what to expect

Healthcare

Happy new year! We are pleased to share the first 2024 edition of GR Korea's healthcare newsletter.

GR Korea team has prepared this newsletter to provide our clients and partners in the healthcare sector with noteworthy developments.

We hope to bring you key updates on a regular basis this year to help you stay informed about the latest developments pertaining to the biotech and pharmaceutical industries.

Please see the full newsletter attached below.